Studies have shown that IMP3 expression is negative in healthy mature tissue and is positive in malignant neoplasms of the colon, kidney, bladder, pancreas, stomach, breast and lung, and is associated with an advanced clinical stage with distant metastases and shorter overall survival7–10. Here, IMP3 is linked to cancer.